Purpose: To analyze two candidate genes, trabecular meshwork inducible glucocorticoid response (MYOC/TIGR) and human dioxin-inducible cytochrome P450 (CYP1B1), in a Chinese pedigree of primary open-angle glaucoma. Methods: In a three-generation family containing 14 members, four of them were patients with primary open-angle glaucoma, one was a glaucoma suspect, and the rest were asymptomatic. All members of the family underwent complete ophthalmologic examinations. Exons of MYOC and CYP1B1 were amplified by polymerase chain reaction, sequenced, and compared with a reference database. Results: Elevated intraocular pressure and impaired visual field were found in all patients. One MYOC heterozygous mutation G367R, in exon 3 was identified in four patients and the suspect, but not in the rest of the family members. Meanwhile, four single nucleotide polymorphisms in MYOC and CYP1B1 genes were found. Conclusions: Although the G367R mutation of MYOC, which causes primary open-angle glaucoma in the form of autosomal dominant inheritance, has been reported in some other ethnicities, it was found in Chinese pedigree for the first time.
(c.1099 G>A, G367R) in exon 3 of MYOC, which was segregated with the disorder within the family and appeared to be the disease-causing gene, was found. It is for the first time, to the best of our knowledge, that G367R mutation was found in Chinese.
METHODS

Clinical examination:
This three-generation pedigree with POAG ( Figure 1 ) was recruited from the out-patient department of Ophthalmology at West China Hospital (Sichuan University, Chengdu, P. R. China). All members of the family underwent the complete ophthalmologic examinations including slit-lamp biomicroscopy, gonioscopic examination, fundoscopic examination, IOP measurement (Canon TX-F Non-contact tonometer; Canon Inc., Tokyo, Japan), and visual field test (Octopus 900; HAAG-STREIT International, Berne, Swiss). Diagnostic criteria for POAG included open anterior chamber angle, elevated IOP (≥22 mmHg), glaucomatous visual field defects and characteristic optic disc damage.
The study was approved by the medical ethics committee of the West China Hospital of Sichuan University. This study follows the principles of the Declaration of Helsinki. All subjects were clinically evaluated by glaucoma specialists. Detection of MYOC and CYP1B1 mutations: Genomic DNA was extracted from 0.2 ml peripheral blood sample with Qiamp Blood Kit (Qiagen, Hilden, Germany) according to the manufacturer's instruction.
Intronic primers flanking the exons were designed (Table  1) based on gene sequences of MYOC (GenBank AF001620) and CYP1B1 (GenBank U56438) and synthesized by Invitrogen (Carlsbad, CA). PCR amplification was performed in a MyCycler thermocycler (Bio-Rad, Hercules, CA). The 30 μl PCR reaction mixtures included 30 ng DNA, 1× PCR buffer, 2.5 mM MgCl2, 0.3 mM of each of dNTPs, 1.5 U Pfu DNA polymerase, and 1.0 μM each of the forward and reverse primers. All reagents used in this procedure were purchased from TaKaRa (Dalian, China). The reactions were incubated at 95 °C for 4 min followed by 35 cycles at 95 °C for 30 s, 58 °C for 30s, and 72 °C for appropriate time (the second exon of MYOC for 30s and the rest for 90s), and then a final extension at 72 °C for 5 to 10 min.
PCR products were directly sequenced by an ABI 377XL automated DNA sequencer (Applied Biosystems, Foster City, CA). Sequence data were compared pair-wise with the published MYOC and CYP1B1 sequences.
RESULTS
The proband and other patients (Table 2):
The proband (II-3) was diagnosed with POAG (both eyes) at the age of 46, with elevated IOPs (26.7 mmHg in the right eye and 23.1 mmHg in the left eye), open anterior chamber angle, enlarged cupdisc ratio of 0.5/0.6(OD/OS) and characteristic glaucomatous visual field defects ( Figure 2 ). Other ocular abnormalities or systemic disorders were not found. The proband's mother (I-2) was diagnosed with POAG at the age of 38, and trabeculectomy was performed for both eyes twenty-one years ago. During this examination, a cup/ disc ratio of 0.95/1.0 (OD/OS), IOPs at 16.7/19.1 mmHg (OD/ OS), and late-stage glaucomatous visual field loss were noticed ( Figure 2 ). II-1 was a JOAG patient, and bilateral trabeculectomies were performed at the age of 34, when his IOPs were as high as 50~60 mmHg (OU). Patient II-6 's onset of the glaucoma was at the age of 20, much earlier than other family members. Her maximal IOPs measured 50 mmHg in the right eye and 65 mmHg in the left eye. She underwent trabeculectomy in both eyes. The cup-disc ratio of both II-1and II-6 was 0.9/0.95 (OD/OS). Patient III-1, 25 years old, abnormalities were found in the rest of the family numbers. Their visual acuity or corrected visual acuity was measured ≥20/20.
MYOC-Sequence analysis of MYOC revealed a heterozygous mutation, c.1099G>A (G367R), in exon 3 in all patients and the suspected one but not in any of the asymptomatic members of the family. The G367R MYOC mutation was cosegregated with the disorder within the family (Figure 3 ). One single nucleotide polymorphism (SNP, g. 23096344C>T) in exon 2 of MYOC was identified.
CYP1B1-No mutation was found. Three CYP1B1 SNPs (g.17120037A>G, g.17120090C>G, and g. 17120026T>C) were identified in exon 3.
DISCUSSION
MYOC was the first identified POAG gene [9] . Previous studies showed that MYOC mutations exist in nearly 3% of adult onset POAG patients and a greater proportion of JOAG patients [15, 16] . In this study, a G to A transition at the first base of codon 367 (in exon 3 of MYOC), which resulted in a glycine to arginine amino acid substitution, was identified, suggesting that MYOC is the glaucoma-causing gene in this family. This mutation has been previously reported in several other ethnic groups: Japanese, Indian, Irish, Swiss, FrenchCanadian, Scottish, and German [17] [18] [19] [20] [21] [22] [23] [24] [25] , however, to the best of our knowledge, this mutation was found in Chinese for the first time.
Based on the literature reviewed, the phenotype of POAG associated with the G367R mutation was summarized in Table  3 : 1) there were no obvious differences between gender; 2) all carriers had open anterior chamber angle; 3) all 6 pedigrees were in autosomal dominant fashion; 4) the patients had relatively high IOP and relatively early onset age; and 6) medical control of IOP were not satisfied in most of the patients, and surgeries were usually needed. The Chinese pedigree with G367R mutation reported in this paper was in general coincidence with the characteristics mentioned.
The phenotypic variations observed here and in previous studies suggest that, in addition to G367R substitution, some as yet unidentified factors (such as the genetic and/or environmental) are responsible for the disease phenotype. Furthermore, POAG is well known to be genetically heterogeneous and several loci have been identified except MYOC. The variations in these loci may contribute to phenotypic variations. Recently, another gene CYP1B1, indeed, has been suggested to modify the glaucoma phenotype [8] . It may act as a modifier of MYOC expression or the two genes may interact via a common pathway [26, 27] . We continued to screen CYP1B1 gene, but no mutations, except three SNPs, were detected. It is known that patients with missense mutations such as G367R are likely to present the normal and mutant mRNA in equal amounts, and then the mRNA is translated into an equal ratio of mutant and normal proteins. Myocilin was thought to be a secreted protein [28] , but mutant Myocilin formed insoluble aggregates that could not be secreted out from human trabecular meshwork (HTM) cells and accumulated intracellularly, then damaged the function of HTM cells and resulted in an increase of aqueous humor outflow resistance [29] [30] [31] . So far, the secretion of G367R mutation myocilin protein has been studied in vitro and in vivo, which revealed the same mechanism above [32] .
In conclusion, the G367R mutation of MYOC in this pedigree appears to be the cause of the disease in this family. This is the first time that this mutation was found in Chinese
